Posted inBiotechnology
Microsimulation Forecasts Dementia Prevalence Across Germany and Its Regions Through 2060
Germany could face a sharply heavier dementia burden by 2060, with the number of people living with the condition potentially…
Posted inBiotechnology
Long-term multimodal study reveals peripheral nerve involvement in wild-type transthyretin amyloidosis
This article reports a prospective 1-year study of peripheral nerve involvement in wild-type transthyretin amyloidosis (ATTRwt) cardiomyopathy. Key findings from…
Posted inBiotechnology
CXCR2 antibodies target tumors and neutrophils, enhancing immunotherapy in ARID1A-deficient pancreatic cancer
Pancreatic cancer has long been regarded as one of the most difficult cancers to treat, not only because malignant cells…
Posted inBiotechnology
Debate Over Cost-Effectiveness of DPYD Testing Before Capecitabine in Metastatic Breast Cancer
A Simple Genetic Test Could Make Capecitabine Treatment Safer for Patients With Metastatic Breast Cancer A routine genetic test performed…
Posted inBiotechnology
Oxygen-Vacancy V6O13/BiMOF/BiVO4 Heterojunction Enables Piezo-Photocatalytic Nitrogen Fixation and Dye Degradation
Nitrogen is everywhere in the atmosphere, yet converting it into a useful chemical remains one of the most demanding challenges…
Posted inBiotechnology
S-Scheme Quantum-Dot Heterojunction Photocatalysts: Structures, Mechanisms, and Design Strategies
Quantum dots are reshaping the design of photocatalysts, offering scientists a way to manipulate light, charge, and chemical reactions at…
Posted inBiotechnology
CUDA-Q Accelerates Adaptive Distribution Generation Using Quantum Walks
Quantum computing is moving into a new phase of experimentation, one in which researchers are no longer asking only whether…
Posted inBiotechnology
Spyre’s rheumatoid arthritis plan toppled by subpar TL1A data
Phase 2 data on Spyre Therapeutics’ anti-TL1A antibody SPY072 in rheumatoid arthritis have fallen short of expectations, prompting the biotech…
Posted inBiotechnology
SK Biopharma pens $795M deal to usher Biohaven’s epilepsy therapy towards hoped-for 2029 launch
SK Biopharmaceuticals has strengthened its epilepsy offering by paying $350 million upfront to help speed Biohaven’s Kv7 ion channel activator…
Posted inBiotechnology
Perovskite Memdiode Neuromorphic Model Simulates Predictive-Coding Failures in Diabetic Neuropathy
A new computational study proposes an unusual way to explore diabetic peripheral neuropathy: by using a simulated perovskite memdiode to…